DE60006412D1 - Oxazinochinolone zur behandlung von viralen infektionen - Google Patents

Oxazinochinolone zur behandlung von viralen infektionen

Info

Publication number
DE60006412D1
DE60006412D1 DE60006412T DE60006412T DE60006412D1 DE 60006412 D1 DE60006412 D1 DE 60006412D1 DE 60006412 T DE60006412 T DE 60006412T DE 60006412 T DE60006412 T DE 60006412T DE 60006412 D1 DE60006412 D1 DE 60006412D1
Authority
DE
Germany
Prior art keywords
oxazinochinolone
treatment
viral infections
infections
viral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60006412T
Other languages
English (en)
Other versions
DE60006412T2 (de
Inventor
Ronald Turner
Suvit Thaisrivongs
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia and Upjohn Co
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co
Application granted granted Critical
Publication of DE60006412D1 publication Critical patent/DE60006412D1/de
Publication of DE60006412T2 publication Critical patent/DE60006412T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE60006412T 1999-10-05 2000-09-28 Oxazinochinolone zur behandlung von viralen infektionen Expired - Fee Related DE60006412T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15774299P 1999-10-05 1999-10-05
US157742P 1999-10-05
PCT/US2000/021985 WO2001025239A2 (en) 1999-10-05 2000-09-28 Oxazinoquinolones useful for the treatment of viral infections

Publications (2)

Publication Number Publication Date
DE60006412D1 true DE60006412D1 (de) 2003-12-11
DE60006412T2 DE60006412T2 (de) 2004-08-26

Family

ID=22565065

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60006412T Expired - Fee Related DE60006412T2 (de) 1999-10-05 2000-09-28 Oxazinochinolone zur behandlung von viralen infektionen

Country Status (17)

Country Link
US (1) US6340680B1 (de)
EP (1) EP1220858B1 (de)
JP (1) JP2003511382A (de)
AR (1) AR032598A1 (de)
AT (1) ATE253578T1 (de)
AU (1) AU773098B2 (de)
CA (1) CA2382691A1 (de)
CO (1) CO5251424A1 (de)
DE (1) DE60006412T2 (de)
DK (1) DK1220858T3 (de)
ES (1) ES2210001T3 (de)
NZ (1) NZ518189A (de)
PE (1) PE20010598A1 (de)
PT (1) PT1220858E (de)
TW (1) TW500724B (de)
WO (1) WO2001025239A2 (de)
ZA (1) ZA200201556B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6673793B2 (en) 2000-07-12 2004-01-06 Pharmacia & Upjohn Co. Oxazinoquinolones useful for the treatment of viral infections
PT1299395E (pt) * 2000-07-12 2005-01-31 Upjohn Co Oxazinoquinolonas uteis para o tratamento de infeccoes provocadas por virus
US6624159B2 (en) * 2000-07-12 2003-09-23 Pharmacia & Upjohn Company Heterocycle carboxamides as antiviral agents
US6821969B2 (en) * 2001-02-13 2004-11-23 Pharmacia & Upjohn Company Thioxazinoquinolones as antiviral agents
AU2002352882A1 (en) 2001-12-20 2003-07-09 Pharmacia And Upjohn Company Pyridoquinoxaline antivirals
JP2005530681A (ja) * 2001-12-20 2005-10-13 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー ピリドキノキサリン抗ウイルス剤
AU2003262946A1 (en) * 2002-08-30 2004-03-19 Pharmacia And Upjohn Company Method of preventing or treating atherosclerosis or restenosis
US20040186131A1 (en) * 2002-08-30 2004-09-23 Wathen Michael W Method of preventing or treating atherosclerosis or restenosis
EP1650192A4 (de) 2003-07-24 2007-03-21 Astellas Pharma Inc Chinolonderivat oder salz davon
EP3849979A1 (de) 2018-09-12 2021-07-21 Novartis AG Antivirale pyridopyrazindionverbindungen
AR120045A1 (es) 2019-09-26 2022-01-26 Novartis Ag Compuestos antivirales de pirazolopiridinona

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4568649A (en) 1983-02-22 1986-02-04 Immunex Corporation Immediate ligand detection assay
US4870168A (en) 1987-02-26 1989-09-26 Bristol-Myers Company 3-Unsaturated alkyl cephems from 3-triflyl cephems
TW222276B (de) * 1992-01-27 1994-04-11 Fujisawa Pharmaceutical Co
US5792774A (en) 1996-02-21 1998-08-11 Chiroscience Limited Quinolones and their therapeutic use
EP0927164A1 (de) 1996-09-10 1999-07-07 PHARMACIA & UPJOHN COMPANY 8-hydroxy-7-substitutierte chinolinderivate als antivirale mittel

Also Published As

Publication number Publication date
ES2210001T3 (es) 2004-07-01
NZ518189A (en) 2004-05-28
US6340680B1 (en) 2002-01-22
PT1220858E (pt) 2004-03-31
PE20010598A1 (es) 2001-05-24
AR032598A1 (es) 2003-11-19
DE60006412T2 (de) 2004-08-26
AU773098B2 (en) 2004-05-13
ZA200201556B (en) 2003-07-30
TW500724B (en) 2002-09-01
CO5251424A1 (es) 2003-02-28
ATE253578T1 (de) 2003-11-15
EP1220858A2 (de) 2002-07-10
AU7700100A (en) 2001-05-10
WO2001025239A2 (en) 2001-04-12
CA2382691A1 (en) 2001-04-12
WO2001025239A3 (en) 2001-11-22
EP1220858B1 (de) 2003-11-05
JP2003511382A (ja) 2003-03-25
DK1220858T3 (da) 2004-01-26

Similar Documents

Publication Publication Date Title
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60234760D1 (de) Phenylindole zur behandlung von hiv
ATE363904T1 (de) Benzimidazol-2-carbamat zur behandlung viraler infektionen und von krebs
ATE275145T1 (de) Chinazolinderivate zur behandlung von tumoren
ATE417602T1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
ATE269303T1 (de) Arylpiperazinyl-cyclohexyl indolderivate zur behandlung von depressionen
DE69903543D1 (de) Formulierungen zur behandlung von magen-speiseröhren reflux
DE60022916D1 (de) Reboxetin zur Behandlung von peripheren Neuropathien
DE60219292D1 (de) Pyrazolderivate zur behandlung von hiv
ATE265860T1 (de) Impstoff zur behandlung von atherosclerosis
DE60019158D1 (de) Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
DE69934877D1 (de) Biochanin-angereicherter extrakt zur behandlung von estrogenabhängigen erkrankungen
DE60136477D1 (de) Retinoide zur behandlung von emphysem
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
ATE384522T1 (de) Medikamente zur chemotherapeutischen behandlung von erkrankungen
DE60030554T8 (de) Verwendungen von et743 zur behandlung von krebs
ATE279386T1 (de) Retinoide zur behandlung von emphysem
DE60021065D1 (de) Virus behandlung
DE60006412D1 (de) Oxazinochinolone zur behandlung von viralen infektionen
DE50105735D1 (de) Chlorzoxazon zur behandlung von psoriasis
ATE273276T1 (de) Cyclobutendion-derivate zur behandlung von artherosclerose
DE60021252D1 (de) Antikonvulsiva zur behandlung von autismus
DE69834937D1 (de) Antibiotika zur behandlung von magengeschwuren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee